chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Narrative:  Admission Date: Aug 22,2021 Discharge Date: Oct 26,2021 Condition of patient at discharge: Stable Disposition of Patient at Discharge: Acute Rehab Primary Diagnosis during Admission/Treatment: Acute respiratory failure in the context of COVID infection 64 YO MALE w/ Asthma-COPD overlap syndrome (ACOS), restrictive lung disease (FEV1 40%, TLC 50%), hx of ABPA, hx of DVT/PE (remote, not on anticoagulation), HTN, HLD, PTSD came to the Emergency Room on 8/22/2021 for SOB and syncope in the setting of covid+, despite full vaccination with Pfizer Covid vaccine on 5/20/2021 and 6/10/2021. His wife then was diagnosed w/ covid approx 1 week prior and he tested positive on August 16th. He was feeling well until the last 3 days when he developed progressive dyspnea, cough w/ yellow sputum, and nausea. He was in his garage when he began to feel dizzy and passed out. His wife found him there, thought to be about 15 minutes later. He stated she did not notice any unusual jerking activity or incontinence. In the Emergency Dept, he was hypoxic requiring HFNC 45L/50%, tachycardic to 120, w/ cough & wheeze. CXR and CT PE indicative of COVID pneumonia. The patient was admitted to the Medical ICU from 8/22/21 to 10/14/21. He was intubated on 8/26/21. Unfortunately, he was out of the window for remdesivir and was not a candidate for baracitinib or monoclonal antibody due to concerns for infection. Patient had a prolonged hospital course while intubated complicated by vent dysynchrony, septic shock, and acute renal failure requiring tablo. He had a trach placed on 9/29/21 and has been off all ventilator support since 10/10/21. Tablo was stopped 9/17 and his renal function has since improved with just PRN Lasix (Serum Creatinine from 10/13 is 0.61). On 10/13, patient was transitioned to a cuffless trach and capping trials were started on 10/14. As far as antimicrobials, patient is currently on nystatin for oral thrush (10/13-preset) and cefepime for pseudomonas and klebsiella PNA (10/3-10/17). As far as feeding, patient passed a barium swallow study on 10/12. He still has NG tube feeds to supplement PO feeds. Once out of the ICU, the patient was stable and required minimal intervention. The patient completed his cefepime course with no evidence of reinfection. While on the ward, follow up chest x-rays were unchanged. White count similarly was within normal limits and stable. The patient was decanulated within the first 48 hours and has tolerated 2-3 liters of oxygen via nasal cannula well. He was dishcharge to an acute rehab facility on 10/26/21.
Immediately he had upper arm soreness and elbow tightness. Patient reported that it was painful  to pull his arm tight to his chest. The upper arm soreness only lasted 2-3 days but the elbow pain has lasted almost a week.
has a bad rash on the front of her face and behind both ears that "looks like measles."; has a bad rash on the front of her face and behind both ears that "looks like measles."; This is a spontaneous report from a contactable consumer or other non hcp.     A 15-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Batch/Lot Number: unknown), via an unspecified route of administration, administered on 19Jul2021 16:00 as single dose for covid-19 immunisation.  The patient medical history was not reported. The patient's concomitant medications were not reported. Caller states her daughter has a bad rash on the front of her face and behind both ears that "looks like measles."  on Jul2021. The outcome of events was not recovered.    Information about lot/batch number has been requested.
After the shot I felt excessively sore in the injection site. There is currently a quarter sized bruise around the injection site. I have also been prone to bruising after the vaccine and have developed a few large bruises on my leg. Avoiding NSAIDS (ibprophen) and only took Tylenol since noticing the bruising.
pt recvd vax 14SEP95 local rxn redness (major), major swelling, ecchymosis, tender to sl touch;high pitched cry since time of vax area very swollen, red, & tender to touch
Husband of patient interviewed on 02/07/2022.  Patient taken to hospital via rescue squad on 02/06 due to extreme lethargy and inability to stay awake.  Admitted to ICU and placed on a ventilator.   Patient also had symptoms:  cough, shortness of breath, diarrhea, difficulty breathing, confusion, and was feverish.  Patient had an abnormal CT of chest.  UNK as to days in hospital per system
pt that only had 1st dose of Shjngrix. It has been 8 months; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (patient received only had 1st dose of Shjngrix, 8 months ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: pt that only had 1st dose of Shjngrix. It has been 8 months). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 09-MAY-2023 The reporter stated that patient only had 1st dose of Shjngrix.  It had been 8 months. The reporter asked whether the patient should patient get 2nd dose now or start 2-dose series over. Till the time of reporting patient did not received 2nd dose, which led to incomplete course of vaccination.
arm discolored and her skin was peeling off; arm discolored and her skin was peeling off; This is a spontaneous report from a contactable pharmacist. A female patient of an unspecified age received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date at single dose for immunisation. The patient's medical history and concomitant medications were not reported. The patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) on an unspecified date and the next day arm was discolored and her skin was peeling off. The reporter asked if this is common.  No follow-up attempts are needed. Information regarding batch/lot number cannot be obtained.
Difficulty breathing. I went to the emergency room after speaking to an on-call nurse on May 1, 2021. In order to get a good breath, I had to periodically do deep inhales and exhales. This was scary and I am concerned about taking a booster shot. I also had major chills; body and muscle aches; dizziness and weakness; fast heartbeat.
Information has been received from a physician concerning a "20 year" old female who on an unspecified date was vaccinated with a first dose of Gardasil (lot # unknown) injection.  On an unspecified date after receiving the first dose of Gardasil the patient developed a nodule at the injection site approximately 1cm in size and was painful upon pressure.  The patient did not have any redness or fever.  Medical attention was sought.  At the time of reporting it was unknown if the patient had recovered.  Follow-up information was received from a nurse.  On an unspecified date the patient had received a second dose of Gardasil and no adverse event was reported.  Additional information is not expected.
Low grade fever (99.4F), myalgia, arthralgia, moderate tenderness at injection sit
Initial report was received 05 February 2011 via a company sponsored web site from a consumer, who is the patient's parent.  A female patient (age and date of birth not reported), had received a second dose of DTP (manufacturer name, lot number, route, site and date of administration not reported) and an unspecified amount of time later, she developed a "bad reaction".  In the middle of the night the patient stopped breathing.  The reporter stated, "somehow I woke up to hear her not breathing.  I picked her up and blew in her face to get her to breath again".  The reporter had the patient sleep on her chest the remainder of the night to make sure the patient would be alright.  It was further noted that the patient has to take antibiotics during outbreaks of whooping.  The reporter noted that this event occurred over 22 years ago, and the patient was now a healthy adult.  No additional information was provided at the time of the report.  Documents held by sender: None.
Information has been received from a physician concerning a 13 year old female who on 18-AUG-2008 was vaccinated with the first dose of GARDISIL (Lot No. 659184/0843X). After receiving the first dose, the patient experienced dizziness and vomiting at the physician's office. At the time of the reporting, the patient had recovered. Additional information has been requested.
Patient felt dizzy after injection(1513 admin time).  given juice  and crackers, feet elevated and vitals taken , elevated BP 169/99, otherwise stable.  Monitored for 30 minutes and dizziness and vitals  improved.  Patient escorted walking  on her own to exit.
PT VACCINATED WITH RECOMBIVAX 36 HRS FOLLOWING THE INJECTION DEVELOPED BLURRED VISION, NAUSEA, VOMITING, & DIARRHEA.  TWELVE HRS LATER, LOST PERIPHERAL VISION IN RT EYE AND DEVELOPED SEVERE HEADACHE. AFTER 72 HRS SYMPTOMS SUBSIDED.
Patient states approximately 5 hours after co-administration he began having chills, swelling in his upper extremity, and severe tenderness. After two days, the swelling had spread to his forearm and he went to see the doctor. The nurse practitioner who saw him stated he had soft tissue inflammation post vaccination administration.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding concomitant medications, concurrent conditions or medical history. On an unspecified date in 2012, also reported as, on or about 2012, the patient was vaccinated with ZOSTAVAX (strength, dose, route, anatomical location, lot number and expiration date were not reported), to obtain permanent prevention and protection against shingles and zoster-related injuries (prophylaxis) as recommended by the healthcare professional. On an unspecified date in 2016, also reported as on or about 2016, the patient experienced shingles (Herpes zoster) and was treated at the physician's office. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX (Vaccination failure) and suffered serious physical, emotional, and economic damages (Emotional distress), as a result of patient's injuries on unknown dates. The patient had and would continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering (Emotional distress) (Pain); extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs included care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (Condition aggravated); lost wages; loss of earnings capacity; and other losses and damages. At the time of the report, the patient was not recovered from emotional distress and pain, and the outcome of the patient regarding the vaccination failure, herpes zoster, quality of life decreased and the pre-existing unspecified conditions aggravated was unknown. The relatedness between ZOSTAVAX and the aforementioned events was assessed as related by the reporter. The reporter determined all the events to be serious due to disability, life-threatening and medically significant.
Erythema patches, urticaria? on face, neck 5-10m post the vaccinations. The skin patches, urticaria disappeated in 2 hrs. No treatment given. Benadryl allergy Elixir prn sent home. Follow up-normal. Crying-normal. Feeding-normal.
Muscle soreness; Pain injection site; I think it is my lymph node but they are like swollen and it keep popping over my collar bone and it is kind of like popping out of my chest and popping back in; This is a spontaneous report from a contactable consumer or other non hcp (patient). A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19, solution for injection, Batch/Lot Number: EWO187), via an unspecified route of administration on 31Jul2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient reported that "I got my vaccine the first dose of the Pfizer vaccine back on 31Jul2021 and after that first and second day everything was cool. I just had the typical muscle soreness and pain at the injection site but recently within the last two days on my left side of my collar bone area, feel like my lymph. I think it was my lymph's node but they were like swollen and it keep popping over my collar bone and it was kind of like popping out of my chest and popping back in and I see there were some of side effects were swollen lymph node and I am just like super freaking out because I already did one to get the vaccine and now this was making me feel like not to take the second shot, just because I had multiple vaccines in my whole entire life and I never had lymph node problem. I was just calling because I was wondering is this like a typical problem that you guys get with like lymph nodes." The outcome of the events were unknown.   Follow-up attempts are completed. No further information is expected.
Developed lightheadedness within 1 minute of receiving the vaccine. She has a history of aversion to needles and similar symptoms to needles in the past.
Patient passed out immediately following vaccine.  He came to immediately after and was able to speak coherently. He did appear pale for several minutes following his fainting episode.  Patient had not eaten anything all day and despite his answers to questions regarding this topic, his wife then stated that he passes out all the time when needles are involved.
My hearing sounded like I was under water and then I started hearing?static? in both ears which has become progressively worse with no relief.
Pt called the day after receiving PN injection. Pt reported pain and moderate swelling at injection site and approximately 8 hrs of chills and intermittent dizziness. Reported reaction to PCP and pharmacy.
L mid arm redness, swelling, increased warmth, pain within 24 hrs of Td given (it does not appear that vaccine was given in deltoid muscle, but rather in the mid arm)
Tightness in throat 45 mins p/vax; no other sx; resolved spontaneously;
initially had low grade fever, headache, chills that started 6-8 hours after the vaccine then abated, went for routine physical examination and found to be hypertensive, BP over 140 systolic taken 3 times in the primary care physician's office.  Later began doing BP monitoring at home, BP running from 130-140 with a high of 154 systolic, diastolic 70-78.  There have been no associated headaches, dizziness, etc.
Crippling fatigue for 5 days Sore arm Unable to stand up or lift my head Shooting & sharp pain on both sides of my body Cold sweats and chills Headache Full body twitches Neurological symptoms worsened: brain fog, short term memory loss, and attentiveness decreased
I took the "Moderna COVID-19 Vaccine EUA" on December 31, 2020. I had pain/soreness at the injection site for 3 days, but I still have other side effects since getting the vaccine. The side effects started out with mild muscle pain and joint pain on the 31st, then in the night and for every day since the vaccine I have had headaches which I am taking ibuprofen for. I also feel quite fatigued since getting the injection. In the last few days I also had cold sweats, and chills yesterday. Today, I still have headache and fatigue.
Bronchitis; Ill feeling; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Ill feeling) and BRONCHITIS (Bronchitis) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Panuveitis.    Concurrent medical conditions included Panuveitis.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) UNK, CF. In 2021, the patient experienced MALAISE (Ill feeling). In August 2021, the patient experienced BRONCHITIS (Bronchitis). In 2021, MALAISE (Ill feeling) and BRONCHITIS (Bronchitis) had resolved.            There was no reported medical history.  Concomitant medications details were not reported.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.   The reporter's causality for the event of Ill feeling and Bronchitis was reported as no reasonable possibility for Humira.  No treatment medication were provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the moderna mailbox were missed to be booked-in.
Pt recvd 3 doses of Engerix-B & 27JAN92 found to be a non-seroconverter;
Ecchymosis at vaccination site, Nausea and vomiting. Myalgias.
Presented to hospital after witnessed GTC seizure. Admitted with status epilepticus. Intubated for airway protection in setting of seizures.  Extubated 1/27 PM.
This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient. A 64 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 28Dec2020 13:15 (Lot number: EL1284) at the age of 64 years as dose 1, single for Covid-19 immunisation. Relevant medical history included: "hypertension" (unspecified if ongoing); "CHOLESTEROL" (unspecified if ongoing), notes: COLESTEROL. There were no concomitant medications. The following information was reported: PAIN (non-serious) with onset 01Feb2021 15:00, outcome "not recovered", described as "Painful stabbing sensation in the area". The event "painful stabbing sensation in the area" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pain. Additional information: Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. No any other medications were received within 2 weeks of vaccination. Patient received Pfizer vaccine, administration date 28Dec2020 (Lot number: EL9261) at the age of 64 years as dose 2. No follow-up attempts are possible. No further information is expected.
Dizziness, headache, nausea, fever, body pain, confusion, swelling of throat and tongue, difficulty breathing, tightness in chest, weakness of arms.
Pt has had soreness then pain in her anterolateral L shoulder after vaccine in April. She has been trying to lift weights, and swim, but has significant limitation of movement in that shoulder accompanied by pain. She has researched and thinks that it might be SIRVA (shoulder injury related to vaccine administration) since temporally related. Reports: limited range of motion, L arm, increasing pain, reports constant pain, reports worsening pain with movement, abduction, extension, flexion, 50% reduction, Can't lift up to get out of bath, Worst 7-8/10- range of motion limited Denies: denies any alterations to skin: redness, bruising, deformities, fevers, chills, numbness or tingling, chest pain, sob, lightheadedness, dizziness
Within 24 hours of recieving the PPSV23 vaccine pt developed pain and redness at the site of injection, fever, body aches and fatigue. She monitored redness by marking with a pen, treated fever with tylenol/motrin. Was seen in office 2 days after vaccination and sent to the hospital for evaluation and management of vaccine reaction. She was treated with IV Abx for cellulitis and hospitalized for 3 days. She is now on an oral course of abx for 10 days. She still has decreased ROM of affected arm.
Pt had completed his 5 year old well checkup on 1/9/04 about 4:30 PM, had his 5 year old shots and went home. But within about 15 minutes Mom called to report allergic reaction and returned at about 4:50 PM. Pt had hives, mild hypotension and somnolence. No wheeze or hypoxemla. Given 0.2mg Epi subcutaneous and responded well, within 1 hour, back to normal. No further reaction.
Exhaustion starting after 2 hours first day , increasing to second day, with simultaneous vomiting and diarrhea second day (30 hrs post vaccine) that lasted 2 hrs
fever; This case was reported by a consumer via call center representative and described the occurrence of fever in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included kidney transplant.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced fever. On an unknown date, the outcome of the fever was recovered/resolved.   It was unknown if the reporter considered the fever to be related to Shingrix.  Additional details were provided as follows: The patient was a friend of the reporter.  The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient received Shingrix and had a fever for two days. This case linked with US2020126270 and US2020126266, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020126270:same reporter US-GLAXOSMITHKLINE-US2020126266:same reporter
At 6:45 p.m., patient c/o feeling light headed. Patient accompanied by her father. Patient asked if she has eaten today, father stated not since lunch. Water, orange juice and snacks provided. VS obtained at 6:47 p.m. 69/40-69-97%RA. Patient remains alert and verbal. VS retaken at 6:55 p.m. 65/39-61-97%RA. Patient remains alert and verbal, RRT called at 6:54 p.m., VS retaken at 6:54 p.m. 87/65-65-97%RA. RRT arrived at 6:55 p.m. MD assessed and interviewed patient/father. Father states systolic normally in 90's. RRT MD had patient get up and walk, patient able and verbalizing feeling better. 7:02 vs retaken 103/85-103-97%RA. Patient and father declined ER. Patient remained in clinic until 7:10 p.m. with no c/o. Patient educated if any adverse reactions occur to go th ER.
7day p/vax pt exp local react w/erythema, swelling, & warmth
Shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Shortness of breath). At the time of the report, DYSPNOEA (Shortness of breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication and treatment information were not reported.